News 6

Inflazome Announces Acquisition by Roche

September 21, 2020Alex0

Inflazome is a pioneering inflammasome company developing orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases Acquisition […]